Cryptocurrency Algorand Decreases More Than 3% Within 24 hours

Algorand's (CRYPTO: ALGO) price has decreased 3.4% over the past 24 hours to $0.11, continuing its downward trend over the past week of -7.0%, moving from $0.12 to its current price.

Algorand’s (CRYPTO: ALGO) price has decreased 3.4% over the past 24 hours to $0.11, continuing its downward trend over the past week of -7.0%, moving from $0.12 to its current price.

The chart below compares the price movement and volatility for Algorand over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.

price_chart

The trading volume for the coin has decreased 39.0% over the past week, while the overall circulating supply of the coin has increased 2.78% to over 7.57 billion. This puts its current circulating supply at an estimated 75.73% of its max supply, which is 10.00 billion. The current market cap ranking for ALGO is #47 at $850.47 million.

supply_and_vol

Powered by CoinGecko API

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Canadian Company Lifeist Says Farewell To Cannabis Business Unit, Turns To Nutraceuticals

Canadian wellness company Lifeist has agreed to sell its CannMart cannabis subsidiaries to 1463663 B.C. for $3.72m. The deal, which is expected to improve cash flow and operational costs, will see all shares of the CannMart Group transferred to the buyer. The consideration of $5m plus adjusted inventory will be paid to Lifeist as follows: $500,000 cash will be paid upon the transaction's completion, with a further $4.5m in a senior secured vendor takeback loan paid through monthly repayments. Additionally, Lifeist will receive equity warrants to acquire 9.9% of Tierra Corp's equity, as parent company of 1463663 B.C. Once the deal is finalised, Lifeist will be freed to operate in the nutraceutical sector, with North America's $88.3bn predicted to grow to $118.7bn by 2028, according to the company.

LFST